Medtronic PLC has submitted new clinical data to the US Food and Drug Administration to support approval of the Micra AV leadless pacemaker for patients with atrioventricular block.
Micra AV is a dual-chamber version of Medtronic’s Micra TPS leadless transcatheter pacemaker system, which Medtronic touts as the world’s smallest pacemaker. Micra TPS has been a commercial success for Medtronic since it was introduced in 2016
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?